Hautarztpraxis Dr Med Matthias Hoffmann
- Address
- Annenstraße 151, 58453 Witten, Germany
Hautarztpraxis Dr Med Matthias Hoffmann - Dermatological Research Center
Hautarztpraxis Dr Med Matthias Hoffmann is a specialized dermatological research center with expertise in chronic inflammatory skin conditions. The practice demonstrates particular proficiency in investigating novel therapeutic interventions for challenging dermatological disorders that significantly impact patients' quality of life.
- Prurigo Nodularis and chronic pruritus management
- Advanced dermatological therapeutic trials
- Investigation of targeted oral therapies for inflammatory skin conditions
The center actively participates in international clinical research programs, including the STOP-PN2 study evaluating povorcitinib for the treatment of Prurigo Nodularis. Their research focuses on assessing both symptom relief, particularly itch reduction, and visible improvement in skin lesions, contributing valuable data to advance treatment options for patients suffering from this debilitating chronic condition.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International5trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hautarztpraxis Dr Med Matthias Hoffmann
lock Showing 1 of 13 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-88545223 in Participants with Active Psoriatic Arthritis | Janssen Cilag International | Phase II | Recruiting | Mar 2026 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amlitelimab | 4 | Unknown | 2022-11-10 | 2024-10-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.